We propose to study the clonal heterogeneity of T lymphocytes in autoimmune diseases, particularly in rheumatoid arthritis. This will be carried out through an analysis of the T cell receptors (TCR). Framework monoclonal antibodies (mAb) against the TCR delta chain (beta F1) and against the TCR beta chain (anti-TCR delta 1) will be used to study the TCR alpha beta and TCR gamma delta proteins from rheumatoid arthritis T cells. The T cells will include the activated T cells from peripheral blood, as well as T cells from synovial fluid and synovial tissue. TCR protein will be characterized by two dimensional gel analyses. TCR gene rearrangements will be examined in Southern blotting analyses. TCR protein will then be isolated for frequently immunization of mice in the production of mAb that may recognize frequently used or cross-reactive TCR gene segment encoded determinants. Complementary used or cross-reactive TCR gene segment encoded determinants. DNA clones corresponding to these gene segments will be cloned and sequenced. Analysis on a more limited basis will be carried out in type 1 diabetes and systemic lupus erythematosus. The framework mAb against the TCR will also be evaluated as diagnostic tools for distinguishing malignant versus benign T- lineage proliferations, based on the discordant expression of CD3 and TCR proteins in neoplasia. All analyses performed will include both receptors, TCR alpha beta and TCR gamma delta. We hope that the proposed studies will help us to understand the role of T cells in autoimmune diseases and that T cell receptors may prove useful in the diagnosis of T-lineage neoplasms.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR039582-03
Application #
3159736
Study Section
Immunological Sciences Study Section (IMS)
Project Start
1988-07-01
Project End
1993-06-30
Budget Start
1990-07-01
Budget End
1991-06-30
Support Year
3
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02215
Behar, S M; Dascher, C C; Grusby, M J et al. (1999) Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J Exp Med 189:1973-80
Behar, S M; Podrebarac, T A; Roy, C J et al. (1999) Diverse TCRs recognize murine CD1. J Immunol 162:161-7
Chen, Y H; Wang, B; Chun, T et al. (1999) Expression of CD1d2 on thymocytes is not sufficient for the development of NK T cells in CD1d1-deficient mice. J Immunol 162:4560-6
Behar, S M; Roy, C; Lederer, J et al. (1998) Clonally expanded Valpha12+ (AV12S1),CD8+ T cells from a patient with rheumatoid arthritis are autoreactive. Arthritis Rheum 41:498-506
Behar, S M; Roy, C; Brenner, M B (1995) Expansions of V alpha 12 CD8+ T-cells in rheumatoid arthritis. Ann N Y Acad Sci 756:130-7
Janson, C H; Grunewald, J; Osterborg, A et al. (1991) Predominant T cell receptor V gene usage in patients with abnormal clones of B cells. Blood 77:1776-80
Wigzell, H; Grunewald, J; Tehrani, M et al. (1991) T cell V-gene usage in man in some normal and abnormal situations. Ann N Y Acad Sci 636:9-19